Latest news

Bioservo has completed a directed issue of approximately SEK 14 million (regulatory information)

Bioservo is investigating the prerequisites for carrying out a directed share issue (regulatory information)

World’s first soft robotic muscle strengthening system. Developed in collaboration with leading Fortune 500 companies

Menu

Partners

Starting with our founding fathers KTH (Royal Institute of Technology, Stockholm) and the Karolinska University Hospital, we have extended our cooperations from a number of renown healthcare institutions to several Fortune 500 companies over the years. This provides us with the solid foundation needed to reach out to everyone in need of extra strength and endurance.

Cooperations
Partners Web 2